Longevity Health Holdings added 44,382 common shares to a prospectus while issuing a $416,667 10% senior secured convertible note due February 29, 2028. Investors get defined disclosure of potential Equity issuance, secured Debt terms and Warrant changes, including a $1.38 exercise price and 712,307 shares issuable.

Key Highlights

  • Puritan Partners LLC is the purchaser and Collateral agent for the secured convertible note.
  • The note proceeds are designated for Working Capital subject to an August 13, 2026 settlement agreement.
  • Warrants issued January 2, 2025 will have an exercise price of $1.38 and 712,307 shares issuable upon exercise.

Longevity Health Holdings, Inc. (OTC: XAGE) is supplementing its prospectus to cover 44,382 shares of common stock and a $416,667 senior secured convertible note. The note creates a direct financial obligation and is due February 29, 2028.

10% Convertible Note and Prospectus Terms

The supplement amends the prospectus dated June 5, 2024, which forms part of registration statement No. 333-279329. The note carries a 10% rate and was issued to Puritan Partners LLC. The note and common stock issuable upon conversion were sold without Securities Act registration under Section 4(a)(2) and/or Rule 506 of Regulation D, based in part on Puritan’s accredited-investor representations. No general solicitation or Advertising was used.

Collateral, Guarantees and Warrant Adjustments

Collateral terms include an amended and restated security agreement and a separate intellectual-property security agreement, each naming Puritan Partners LLC as collateral agent. Longevity Health will use the note proceeds for working capital, subject to the settlement agreement dated August 13, 2026. The transaction also changes warrants issued January 2, 2025, reducing the exercise price from $3.3557 to $1.38 and increasing shares issuable upon exercise from 292,929 to 712,307.